A detailed history of Vanguard Group Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 6,180,450 shares of INVA stock, worth $119 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,180,450
Previous 6,286,013 1.68%
Holding current value
$119 Million
Previous $95.8 Million 5.8%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$14.4 - $16.4 $1.52 Million - $1.73 Million
-105,563 Reduced 1.68%
6,180,450 $101 Million
Q1 2024

May 10, 2024

SELL
$14.56 - $16.78 $6.21 Million - $7.16 Million
-426,430 Reduced 6.35%
6,286,013 $95.8 Million
Q4 2023

Feb 14, 2024

SELL
$12.32 - $16.27 $61,526 - $81,252
-4,994 Reduced 0.07%
6,712,443 $108 Million
Q3 2023

Nov 14, 2023

SELL
$12.37 - $13.89 $882,191 - $990,593
-71,317 Reduced 1.05%
6,717,437 $87.3 Million
Q2 2023

Aug 14, 2023

SELL
$11.39 - $13.72 $4.66 Million - $5.61 Million
-408,817 Reduced 5.68%
6,788,754 $86.4 Million
Q1 2023

May 15, 2023

BUY
$10.73 - $13.6 $1.35 Million - $1.7 Million
125,359 Added 1.77%
7,197,571 $81 Million
Q4 2022

Feb 10, 2023

BUY
$11.8 - $13.78 $876,256 - $1.02 Million
74,259 Added 1.06%
7,072,212 $93.7 Million
Q3 2022

Nov 14, 2022

BUY
$11.61 - $15.22 $313,504 - $410,985
27,003 Added 0.39%
6,997,953 $81.2 Million
Q2 2022

Aug 12, 2022

BUY
$14.32 - $19.88 $2.11 Million - $2.93 Million
147,560 Added 2.16%
6,970,950 $103 Million
Q1 2022

May 13, 2022

BUY
$15.39 - $20.25 $356,971 - $469,698
23,195 Added 0.34%
6,823,390 $132 Million
Q4 2021

Feb 14, 2022

BUY
$15.91 - $18.72 $1.6 Million - $1.88 Million
100,475 Added 1.5%
6,800,195 $117 Million
Q3 2021

Nov 12, 2021

SELL
$13.06 - $17.24 $1.28 Million - $1.69 Million
-98,297 Reduced 1.45%
6,699,720 $112 Million
Q2 2021

Aug 13, 2021

BUY
$11.45 - $13.96 $77.8 Million - $94.9 Million
6,798,017 New
6,798,017 $91.2 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.35B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.